**NM signifies a non meaningful value. A dash signifies the data is not available.

Synaffix’s glycan-based antibody–drug conjugate technology is experiencing strong demand, based on its potential to improve safety and efficacy of cancer therapies without genetic engineering.

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› by Rory Evans The Milwaukee Packout toolboxes click together for convenient and ...

I've been writing about software and hardware for PCMag for more than 40 years, focusing on operating systems, office suites, and communication and utility apps. I've specialized in everything related ...